PATENT CLAIM ANALYSIS

Application Number: 15781987
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "557000"]

Abstract:
A drug combination with antitumor effects, contains styrene acid derivatives and antitumor medicaments with same or different specifications of unit preparations that can be simultaneously or separately administrated, as well as pharmaceutically acceptable carriers. The joint use of trans-styrene acid derivatives and antitumor drugs provides synergistic action, and the use of trans-styrene acid derivatives combined with a part of antitumor drugs can further exert the toxicity attenuation effects, showing a good clinical application prospect.

Claim (Index 24):
The method according to  claim 23 , characterized in that said drug for the treatment of lung cancer is that treating small cell lung cancer.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 94.0
- Lexical Diversity: 1.50943
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11202507', '15925830', '12787095', '15300688', '16085861']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7415125180217849
- 35 USC 102 Novelty (BERT): 0.5168615488754086
- Combined Prediction Score: 0.7190474211071471
- Mean Citation Score: 245.34796
- Max Citation Score: 251.55412
- Similarity Product: 161.55691546894792

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test